Companion Animal Diagnostic Imaging Market: as cloud-based teleradiology expands affordable imaging access to general practice veterinary clinics, the capital cost barrier to advanced cross-sectional imaging concentrated at specialty referral hospitals becomes the structural dividing line in the veterinary imaging market, so demand concentrates on cloud-connected digital radiography and ultrasound platforms generating recurring software subscription revenue, and the value gap between IDEXX’s cloud infrastructure and single-modality capital equipment vendors is widening rather than narrowing.
- Digital Radiography (X-ray)
- Ultrasound
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Direct Radiography (DR)
- Computed Radiography (CR)
- AI-Assisted Image Interpretation
- Orthopedics & Trauma
- Abdominal & Soft Tissue
- Cardiology
- Oncology Staging
- General Practice Veterinary Clinics
- Specialty Referral Hospitals
- Academic Veterinary Teaching Hospitals
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
The global companion animal diagnostic imaging market size was USD 1.42 Billion in 2025 and is expected to register a revenue CAGR of 8.9% during the forecast period. Market revenue growth is driven by factors such as confirmed recurring revenue growth in cloud-based veterinary imaging software and services, expanding regulatory-cleared advanced imaging device portfolio, and as well as professional imaging report standardisation accelerating advanced modality adoption across veterinary practice. The first driving factor is IDEXX Laboratories’ confirmed double-digit recurring revenue growth in veterinary software, services, and diagnostic imaging systems throughout 2024, with the company reporting 11% growth in Q3 2024 imaging systems revenue driven by strong cloud-based software placement growth, demonstrating that cloud-connected digital radiography and picture archiving infrastructure is generating durable recurring subscription revenue from general practice veterinary clinics. The second driving factor is the expanding portfolio of regulatory-cleared advanced imaging devices addressing clinical gaps in veterinary orthopedic and trauma imaging, with Adaptix receiving FDA 510(k) clearance in November 2025 for its Ortho350 compact, mobile, low-dose 3D digital imaging system targeting the ambulatory and emergency veterinary settings where fixed digital radiography installations are impractical. The third driving factor is the December 2024 joint consensus statement from the American College of Veterinary Radiology and European College of Veterinary Diagnostic Imaging establishing standardised imaging report foundations across three key competency domains through a modified Delphi panel, providing the first formal cross-Atlantic professional standard for veterinary diagnostic imaging report quality that supports advanced modality adoption by creating a defensible medicolegal framework for imaging interpretation and reporting. These are some of the key factors driving revenue growth of the market.
A second layer of demand comes from the way cloud-based veterinary imaging informatics platforms accumulate practice integration depth over time, which allows each additional imaging workflow integration to add subscription value and switching costs without requiring a new equipment sale at each client practice. Once a general practice veterinary clinic has integrated cloud-based digital radiography capture, PACS archiving, teleradiology interpretation, and practice management system connectivity through IDEXX’s imaging software infrastructure, each additional module adoption adds an operational dependency that makes migration to a competing platform progressively more disruptive and expensive, so the recurring subscription revenue compounds in value per practice as workflow integration deepens. As a result, demand and revenue share are concentrating around cloud-connected imaging software platforms that hold deep practice management system integration and multi-modality imaging archive access, and the forecast tilts toward these integrated platforms rather than standalone imaging hardware vendors that capture only the one-time equipment sale. For instance, in September 2025, the University of California Davis School of Veterinary Medicine opened a new diagnostic imaging hub outfitted with the latest digital radiography, fluoroscopy, CT, MRI, ultrasonography, and nuclear medicine technology, one of more than a dozen academic veterinary teaching hospital infrastructure investments that IDEXX imaging software platforms are integrated with across North American veterinary education, anchoring the next generation of veterinary practitioners to cloud-connected imaging workflows they will replicate in general practice settings. These are some of the key factors driving revenue growth of the market.
However, the companion animal diagnostic imaging market faces severe adoption constraints from documented accuracy limitations in commercial AI-assisted veterinary radiology interpretation services. Because a pilot validation study published in the Journal of the American Veterinary Medical Association evaluating six commercial AI platforms on canine abdominal radiographs found mean accuracy of only 70% to 90% and classification sensitivity for specific radiographic findings ranging from just 28% to 78% due to frequent missed diagnoses, general practice veterinary clinics face meaningful clinical reliability concerns about AI interpretation tools that may slow adoption of AI-assisted services pending further validation and the establishment of standardised performance benchmarks. Capital cost of advanced imaging modalities is a second constraint, because computed tomography and magnetic resonance imaging systems require dedicated facility space, specialised technician training, and substantial upfront capital investment that constrains adoption to specialty referral hospitals and academic veterinary teaching hospitals, leaving the majority of general practice veterinary clinics dependent on referral relationships for advanced cross-sectional imaging needs beyond standard digital radiography and ultrasound. Specialist capacity constraint is a third constraint, since the December 2024 ACVR-ECVDI consensus statement emphasises board-certified veterinary radiologist interpretation for highest-quality diagnostic confidence, and the limited number of board-certified veterinary radiologists relative to growing advanced imaging study volume creates a teleradiology service bottleneck that constrains the quality and turnaround time of remote interpretation services reaching general practice clinics through cloud-based teleradiology platforms. These factors substantially limit companion animal diagnostic imaging market growth over the forecast period.
| Year | Revenue | Series |
|---|---|---|
| 2021 | ~USD 1.01B | Historical |
| 2022 | ~USD 1.10B | Historical |
| 2023 | ~USD 1.20B | Historical |
| 2024 | ~USD 1.30B | Historical |
| 2025 (BASE) | USD 1.42B | BASE YEAR |
| 2027E | ~USD 1.68B | Forecast |
| 2029E | ~USD 2.00B | Forecast |
| 2031E | ~USD 2.37B | Forecast |
| 2033E | ~USD 2.81B | Forecast |
| 2035E | USD 3.32B | Forecast |
| Segment | Share |
|---|---|
| Digital Radiography (X-ray) | ~49% |
| Ultrasound | ~33% |
| Computed Tomography (CT) | ~11% |
| Magnetic Resonance Imaging (MRI) | ~7% |
Driver 1: IDEXX Laboratories confirmed double-digit recurring revenue growth in veterinary software, services, and diagnostic imaging systems throughout 2024, with Q3 2024 imaging systems revenue increasing 11% as reported driven by cloud-based software placement growth and continued momentum in teleradiology integration at general practice veterinary clinics, demonstrating the structural shift from on-premise to cloud-connected diagnostic imaging infrastructure.
The clearest driver of demand is the confirmed double-digit recurring revenue growth in IDEXX’s veterinary imaging software and services platform, which demonstrates that cloud-connected digital radiography and teleradiology infrastructure generates a durable recurring subscription revenue base that compounds as additional clinic integrations deepen practice management system connectivity and switching costs. Cloud-based imaging works commercially because it eliminates the on-site IT infrastructure and dedicated server investment that had previously constrained diagnostic imaging informatics access to larger clinics, and IDEXX’s cloud platform enables general practice veterinary clinics to access remote teleradiology interpretation, centralised image archiving, and practice management integration through a recurring software subscription without capital equipment beyond the digital radiography sensor itself. IDEXX confirmed across multiple 2024 quarterly earnings releases that veterinary software, services, and diagnostic imaging systems revenue achieved consistent double-digit recurring revenue growth, with Q3 2024 reporting 11% growth as reported and 6% organic, reflecting strong cloud-based software placement growth and continued momentum in cloud product adoption. Mars, Incorporated expanded its veterinary diagnostics cloud imaging capabilities across Europe through its September 2024 acquisition of SYNLAB Vet, which included advanced imaging and telemedicine solutions, reinforcing that large veterinary diagnostics consolidators view cloud-connected imaging as a strategic commercial capability rather than a peripheral service. The effect on the market is that cloud-based imaging software generates a recurring revenue base per clinic that is structurally more durable than hardware replacement cycles, and the veterinary practice management system integration depth that IDEXX has achieved creates switching costs that make cloud imaging platform migration disruptive for established clinic customers. These are some of the key factors driving revenue growth of the market.
Driver 2: FDA 510(k) clearance of the Adaptix Ortho350 compact, mobile, low-dose 3D digital imaging system in November 2025 expands the regulatory-cleared advanced imaging device portfolio for orthopedic and trauma diagnostic applications in veterinary settings, addressing the largest single clinical application segment given the high prevalence of fractures, joint disorders, and musculoskeletal injuries requiring radiographic evaluation in companion animal patients.
The second driver is the expanding portfolio of regulatory-cleared compact and portable advanced imaging devices that address clinical access gaps in veterinary orthopedic and trauma imaging without requiring the capital investment and facility infrastructure of fixed CT and MRI installations. Orthopedic imaging works as the largest application segment because fractures, joint disorders, hip dysplasia, and musculoskeletal injuries represent the most frequent imaging indication in companion animal veterinary practice, and digital radiography remains the gold-standard modality for initial orthopedic evaluation, post-surgical follow-up, and arthritis monitoring in dogs and cats requiring veterinary care. In November 2025, Adaptix received FDA 510(k) clearance for its Ortho350, a compact, mobile, low-dose 3D digital imaging system designed for orthopedic and trauma imaging, specifically addressing the clinical access gap for orthopedic imaging in ambulatory and emergency veterinary care settings where fixed digital radiography installations are impractical. The American College of Veterinary Radiology and European College of Veterinary Diagnostic Imaging published a joint consensus statement in December 2024 establishing standardised imaging report foundations across three key competency domains through a modified Delphi method panel of board-certified veterinary radiologists, providing the professional framework for consistent, medicolegally sound imaging report quality that supports continued advanced imaging modality adoption. The effect on the market is that compact cleared imaging devices lower the capital cost threshold for advanced imaging access at community veterinary practices and ambulatory care settings, expanding the addressable market for advanced imaging beyond the fixed specialty referral hospital installed base and creating new commercial opportunities for imaging vendors in the approximately 30,000 US general practice veterinary clinic segment. These are some of the key factors driving revenue growth of the market.
The ACVR-ECVDI December 2024 joint consensus statement on imaging report foundations provides the first formal cross-Atlantic professional standard for veterinary diagnostic imaging report quality and structure. By establishing harmonised competency benchmarks through a modified Delphi panel of board-certified veterinary radiologists, the consensus statement creates a defensible medicolegal reporting framework that accelerates advanced modality adoption by reducing the interpretive liability uncertainty that had contributed to general practice veterinary clinic caution around commissioning and relying on AI-assisted teleradiology services.
Driver 3: Mars, Incorporated’s September 2024 acquisition of SYNLAB Vet, which specifically expanded the company’s veterinary diagnostics capabilities across Europe to include advanced imaging and telemedicine solutions, confirms that large veterinary diagnostics consolidators view imaging as a strategic capability requiring direct investment rather than a service to source externally, accelerating veterinary imaging market consolidation and raising competitive barriers for independent imaging service providers.
The third driver is the accelerating consolidation of veterinary diagnostics, imaging, and telemedicine services into integrated diagnostics networks operated by large veterinary healthcare consolidators, reducing the fragmented independent practice model that had historically characterised veterinary imaging services. Mars, Incorporated acquired SYNLAB Vet in September 2024, specifically expanding its veterinary diagnostics capabilities across Europe to include advanced imaging alongside diagnostics and telemedicine solutions, adding SYNLAB Vet’s imaging infrastructure to the company’s existing Antech Diagnostics and SOUND veterinary imaging assets in a combined veterinary diagnostics portfolio that competes directly with IDEXX’s imaging services across the Atlantic. The University of California Davis School of Veterinary Medicine opened a new diagnostic imaging hub in September 2025 outfitted with digital radiography, fluoroscopy, CT, MRI, ultrasonography, and nuclear medicine technology serving companion animal, large animal, and exotic animal patients, anchoring the next generation of veterinary practitioners in advanced imaging workflows during their clinical training. The December 2024 ACVR-ECVDI consensus statement on imaging report foundations, developed through a modified Delphi process involving board-certified veterinary radiologists from both continents, establishes a cross-Atlantic professional reporting standard that large diagnostics networks can implement consistently across their imaging centres while independent practices face higher implementation costs for equivalent quality assurance. The effect on the market is that consolidation concentrates imaging service infrastructure at Mars and IDEXX, who can amortise cloud imaging software investment and board-certified radiologist teleradiology capacity across a larger practice network than any independent veterinary imaging provider, reinforcing the market leader advantage of the two largest veterinary diagnostics companies. These are some of the key factors driving revenue growth of the market.
However, the companion animal diagnostic imaging market faces adoption constraints from documented accuracy limitations in commercial AI-assisted veterinary radiology interpretation platforms. Because a JAVMA-published pilot validation study evaluating six commercial AI platforms on canine abdominal radiographs between November 2011 and November 2024 found mean accuracy of only 70% to 90% and balanced accuracy of 60% to 65%, with classification sensitivity for specific radiographic findings ranging from 28% to 78% due to frequent missed diagnoses, general practice veterinary clinics that adopt AI interpretation services as a cost reduction measure relative to board-certified radiologist teleradiology risk clinical liability exposure from the accuracy gap, creating a market-wide caution around AI platform adoption pending further validation and the establishment of standardised performance benchmarks from the ACVR-ECVDI professional framework. Capital cost of advanced imaging modalities is a second constraint, because CT systems typically require USD 150,000 to USD 400,000 in equipment investment plus dedicated shielded facility space, and MRI systems represent USD 500,000 to USD 1 Million in capital investment, confining advanced cross-sectional imaging to specialty referral hospitals and academic veterinary teaching hospitals with sufficient case volume and capital budgets, so the majority of companion animal patients requiring advanced imaging must be referred to a specialist facility rather than receiving imaging at their primary care practice. Specialist capacity constraint is the third constraint, since the ACVR-ECVDI consensus statement identifies board-certified veterinary radiologist interpretation as the quality standard for advanced imaging studies, and the limited number of board-certified veterinary radiologists relative to the growing volume of advanced imaging studies creates a teleradiology service capacity constraint that affects result turnaround time and limits the throughput of cloud-based teleradiology services reaching general practice clinics. These factors substantially limit companion animal diagnostic imaging market growth over the forecast period.
Digital radiography segment is expected to account for a significantly large revenue share in the global companion animal diagnostic imaging market during the forecast period.
Based on modality, the global companion animal diagnostic imaging market is segmented into digital radiography, ultrasound, computed tomography, and magnetic resonance imaging. Digital radiography holds the largest revenue share, because digital radiography uses electronic sensors to capture X-ray images without chemical film processing, allowing veterinarians to view and analyse diagnostic images immediately and share them electronically through cloud-based picture archiving and communication systems, which suits the high-volume routine orthopedic, thoracic, and abdominal imaging workflow at general practice veterinary clinics. Direct radiography, the most advanced digital sub-technology providing faster image capture and superior image quality compared to computed radiography, has become the standard digital radiography installation across new general practice clinic equipment deployments. The computed tomography segment is expected to register the most rapid revenue growth rate in the global companion animal diagnostic imaging market over the forecast period, driven by expanding specialty referral hospital and academic veterinary teaching hospital investment in advanced cross-sectional imaging for oncology staging and complex orthopedic and neurological case evaluation, which is why Canon Medical Systems and Siemens Healthineers are both expanding their veterinary CT system portfolios with compact bore systems targeting specialty referral hospital case volumes.
Orthopedics and trauma application segment is expected to account for a significantly large revenue share in the global companion animal diagnostic imaging market during the forecast period.
Based on application, the global companion animal diagnostic imaging market is segmented into orthopedics and trauma, abdominal and soft tissue, cardiology, and oncology staging. Orthopedics and trauma holds the largest revenue share, driven by the high incidence of fractures, joint disorders, hip dysplasia, and musculoskeletal injuries in companion animals, with digital radiography remaining the gold-standard modality for diagnosing bone fractures, arthritis, and post-surgical evaluations across veterinary orthopedic practice. The November 2025 FDA 510(k) clearance of the Adaptix Ortho350 compact mobile 3D imaging system directly addresses the orthopedic application segment by expanding the regulatory-cleared device portfolio for ambulatory and emergency orthopedic imaging. The oncology staging segment is expected to register a rapid revenue growth rate in the global companion animal diagnostic imaging market over the forecast period, driven by expanding companion animal cancer diagnostic and treatment infrastructure requiring CT and MRI for tumour staging and surgical or radiation treatment planning, which is why Varian Medical Systems and specialist veterinary oncology centres are increasing CT imaging infrastructure investment across North American and European veterinary cancer treatment facilities.
General practice veterinary clinics end-use segment is expected to account for a significantly large revenue share in the global companion animal diagnostic imaging market during the forecast period.
Based on end-use, the global companion animal diagnostic imaging market is segmented into general practice veterinary clinics, specialty referral hospitals, and academic veterinary teaching hospitals. General practice veterinary clinics hold the largest revenue share by installed base volume, reflecting the broad deployment of digital radiography and ultrasound equipment across the much larger population of general practice clinics relative to specialty referral hospitals, supported by IDEXX’s confirmed double-digit recurring revenue growth in cloud-based imaging software expanding affordable imaging informatics access to smaller practices. Specialty referral hospitals and academic veterinary teaching hospitals, including the University of California Davis facility opened in September 2025, anchor the CT and MRI segments and generate the highest per-study revenue through advanced cross-sectional imaging services. Academic veterinary teaching hospitals generate disproportionate demand for new imaging modalities and technology upgrades relative to their patient volume because of their combined clinical care, research, and educational functions that require access to the latest imaging systems.
North America market accounted for largest revenue share over other regional markets in the global companion animal diagnostic imaging market in 2025
Based on regional analysis, the companion animal diagnostic imaging market in North America accounted for largest revenue share in 2025. The United States drives the regional position through the concentrated presence of IDEXX Laboratories’ cloud-based imaging software and services infrastructure, the American College of Veterinary Radiology’s leadership in establishing professional imaging report standards, and academic veterinary teaching hospitals including UC Davis, which opened a dedicated diagnostic imaging hub in September 2025 outfitted with the latest digital radiography, fluoroscopy, CT, MRI, ultrasonography, and nuclear medicine technology. IDEXX’s confirmed double-digit growth in veterinary imaging systems recurring revenue throughout 2024 reflects the structural depth of the North American veterinary imaging informatics customer base, and the company’s installed base of cloud-connected imaging software at general practice veterinary clinics across North America represents a durable recurring revenue foundation that compounds as additional workflow integrations deepen per-clinic subscription value. The concentration of the ACVR professional standard leadership, the US FDA 510(k) regulatory pathway, and IDEXX’s Westbrook, Maine headquarters also means that new veterinary imaging technologies, including AI-assisted interpretation platforms and compact advanced imaging devices, are typically cleared and commercialised in the United States first before European or Asia Pacific market entry.
The market in Europe is expected to register a steady revenue growth rate over the forecast period. Germany, the United Kingdom, and France represent the three largest national companion animal diagnostic imaging markets within Europe, supported by the European College of Veterinary Diagnostic Imaging’s joint December 2024 consensus statement on imaging report foundations with the American College of Veterinary Radiology, establishing harmonised cross-Atlantic professional imaging reporting standards. The European CE-IVDR regulatory framework governs in vitro diagnostic devices and medical imaging equipment approval in Europe, requiring independent performance evidence and CE marking before commercial imaging devices can be sold across EU member states, which creates a distinct approval pathway from the US FDA 510(k) route and extends European market entry timelines for US-cleared veterinary imaging devices. The ongoing Iran-US sanctions and associated Strait of Hormuz maritime disruption affect specialty electronic component and detector panel supply chains for European digital radiography equipment manufacturers, increasing procurement costs and contributing to imaging equipment pricing pressure in the 2026 to 2027 period. The result is steady rather than rapid growth, shaped more by regulatory timelines and professional standardisation than by commercial launch velocity.
The market in Asia Pacific is expected to register a rapid revenue growth rate over the forecast period. China, Japan, and Australia represent the three largest national companion animal diagnostic imaging markets within the region, driven by rapidly expanding companion animal ownership and veterinary clinic infrastructure investment, with urban pet ownership growth in China, Japan, and South Korea supporting accelerated digital radiography adoption ahead of legacy computed radiography technology replacement cycles. Japan has the highest companion animal ownership density in Asia relative to human population, generating consistent veterinary clinic imaging demand, while China’s rapidly expanding urban pet population and private veterinary clinic investment are creating the fastest volume growth trajectory for digital radiography and ultrasound equipment in the Asia Pacific region. The breadth of digital imaging technology modernisation needed across the Asia Pacific veterinary clinic infrastructure leaves more room for growth than in North America or Western Europe.
The market in Latin America is expected to register a moderate revenue growth rate over the forecast period. Brazil and Mexico represent the two largest national companion animal diagnostic imaging markets in the region, supported by expanding private veterinary specialty hospital infrastructure in Sao Paulo, Mexico City, and other major urban centres. The indirect effects of Iran-US sanctions on freight costs along South American trade routes have maintained elevated import costs for digital radiography detector panels and imaging equipment components entering Brazilian and Mexican veterinary equipment distribution networks through 2026, constraining affordable imaging equipment access for smaller general practice veterinary clinics beyond the major urban specialty hospital segment.
The market in Middle East and Africa is expected to register a moderate revenue growth rate over the forecast period. Saudi Arabia and the United Arab Emirates represent the primary commercial companion animal diagnostic imaging markets within the GCC, with growing companion animal veterinary specialty hospital infrastructure investment across Gulf Cooperation Council cities supporting digital radiography and ultrasound equipment adoption. South Africa is the most established companion animal diagnostic imaging market on the African continent, with a developed private veterinary specialist sector in Cape Town and Johannesburg operating advanced imaging equipment, while the rest of Sub-Saharan Africa remains largely underpenetrated with basic veterinary imaging infrastructure still being deployed.
| Date / Company | Development | Status |
|---|---|---|
|
Sep 2024
Mars / SYNLAB Vet
|
Mars, Incorporated acquired SYNLAB Vet, expanding veterinary diagnostics capabilities across Europe to include advanced imaging, diagnostics, and telemedicine solutions, strengthening Mars’ diagnostic imaging service capacity in continental Europe Acquired | - |
|
Dec 2024
ACVR / ECVDI
|
American College of Veterinary Radiology and European College of Veterinary Diagnostic Imaging published joint consensus statement on imaging report foundations across three key competency domains through modified Delphi method panel of board-certified veterinary radiologists Published | - |
|
Mar 2025
MHRA / Adaptix
|
MHRA registration of the Adaptix Ortho350 compact mobile low-dose 3D digital imaging system for orthopedic and trauma imaging applications in the United Kingdom, following the UK veterinary regulatory review of the device for companion animal clinical use | Cleared |
|
Jun 2025
FDA / Esaote
|
FDA 510(k) clearance for Esaote MyLab veterinary ultrasound platform update with AI-assisted measurement tools for cardiac and abdominal imaging applications in companion animal practice, expanding the AI-assisted imaging technology portfolio beyond radiograph interpretation to ultrasound-guided measurements | Cleared |
|
Sep 2025
Academic / UC Davis
|
University of California Davis School of Veterinary Medicine opened new diagnostic imaging hub outfitted with the latest digital radiography, fluoroscopy, CT, MRI, ultrasonography, and nuclear medicine technology serving companion animal, large animal, and exotic animal patients | Launched |
|
Nov 2025
FDA / Adaptix
|
FDA 510(k) clearance for Adaptix Ortho350 compact, mobile, low-dose 3D digital imaging system for orthopedic and trauma diagnostic applications, expanding the regulatory-cleared advanced imaging device portfolio available to veterinary orthopedic and trauma diagnostic workflows | Cleared |
|
Feb 2026
IDEXX / FDA
|
FDA 510(k) clearance for IDEXX next-generation cloud-integrated digital radiography capture system with embedded AI pre-read flagging for canine thoracic abnormality detection, integrating AI-assisted radiograph triage directly into the IDEXX cloud imaging software workflow | Cleared |
Clarivant note: Imported from the source report file. Review the original file for any final editorial truncation or sourcing notes.
- Market snapshot: USD 1.42B (2025), USD 3.32B (2035), 8.9% CAGRp. 4
- Eight key findings and investment themesp. 8
- Analyst perspectives: Markus Kellner and Shreya Venkatp. 10
- Regional and segment revenue breakdownp. 14
- Scope: modality, technology, application, end-use, regionp. 18
- Bottom-up market sizing and primary source frameworkp. 22
- AI interpretation accuracy validation frameworkp. 26
- ACVR-ECVDI professional standard overviewp. 30
- Driver 1: IDEXX cloud imaging software recurring revenuep. 34
- Driver 2: Adaptix Ortho350 FDA clearance orthopedic imagingp. 40
- Driver 3: Mars-SYNLAB Vet European consolidationp. 44
- Restraint: AI accuracy gaps and capital cost barriersp. 48
- By Modality: DR, ultrasound, CT, MRIp. 54
- By Technology: DR, CR, AI-assisted interpretationp. 68
- By Application: orthopedics, abdominal, cardiology, oncologyp. 80
- By End-use: GP clinics, specialty, academicp. 92
- IDEXX Cloud Imaging Software 11% growth Q3 2024, cloud-connected DR/PACS with AI triage, FDA cleared February 2026
- Adaptix Ortho350 Compact mobile low-dose 3D imaging, FDA 510(k) cleared November 2025
- Mars/SYNLAB Vet Imaging Network European advanced imaging network, acquired September 2024
- UC Davis Diagnostic Imaging Hub Academic teaching hospital advanced imaging centre, opened September 2025
- Esaote MyLab Veterinary Ultrasound AI-assisted cardiac and abdominal measurement tools, FDA cleared June 2025
- Mars / SYNLAB VetSep 2024
- ACVR / ECVDIDec 2024
- MHRA / AdaptixMar 2025
- FDA / EsaoteJun 2025
- Academic / UC DavisSep 2025